ArticleMultiple sclerosis journal - experimental, translational and clinical

Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosis.

Alyssa N Nylander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.